Analytical validation of hepatitis B core‐related antigen (HBcrAg) using dried blood spots (DBS)

Limited access to nucleic acid testing (NAT) to quantify HBV DNA levels, an essential tool to determine anti‐HBV treatment eligibility, represents a significant barrier to scale up HBV diagnostic services in resource‐limited countries. Hepatitis B core‐related antigen (HBcrAg) has the potential to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimakawa, Yusuke, Vernoux, Laura, Gabassi, Audrey, Mercier‐Delarue, Séverine, Vincent, Jeanne Perpétue, Simon, François, Maylin, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247985/
https://www.ncbi.nlm.nih.gov/pubmed/33599049
http://dx.doi.org/10.1111/jvh.13489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247985/
https://www.ncbi.nlm.nih.gov/pubmed/33599049
http://dx.doi.org/10.1111/jvh.13489

Ejemplares similares